iPad Affects Shunt Settings

The settings of programmable shunt devices used to treat brain swelling in children can be altered by magnetic fields, such as those given off by the Apple iPad 2.

By | June 26, 2012

Matthew Downey" > Wikimedia Commons, Matthew Downey


Children suffering from hydrocephalus, the abnormal accumulation of cerebrospinal fluid (CSF) in the brain, should be careful when using Apple’s popular tablet, the iPad 2: if held within 2 inches of the magnetically programmable shunt devices often used to treat the disorder, the computer’s magnets can change its settings, causing the shunt to malfunction, according to a study published in the August 2012 issue of the Journal of Neurosurgery: Pediatrics.

The authors initiated the study after having issues with a programmable shunt in a four-month-old girl patient who received a shunt with a magnetically programmable valve to regulate the flow of CSF. After the girl’s mother used an iPad 2 while holding her daughter, the doctors found that the patient’s shunt valve settings had been changed.

The iPad 2, unlike the original iPad, contains several magnets, and users often encase it in the magnetic Apple Smart Cover. These magnets generate magnetic fields that can adjust the shunt’s settings, which are normally changed by physicians using specialized magnets. After exposing programmable shunt valves to an iPad2 (with and without the Smart Cover), the researchers found that at distances of 0-1 centimeters, 58 percent of the valves exposed to the iPad 2 with the Smart Cover and 67 percent of those exposed to the iPad 2 with no cover had changed. The frequency of change diminished with increasing distance, and no valve setting changes occurred at greater than 5 centimeters.

Of course, the Apple tablet isn’t the only threat to these programmable devices, as its magnetic field is of similar strength to many household magnets. But it’s important that patients and caregivers are aware of the possible complications, and take appropriate precautions, the authors said.

Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras